epididymo-orchitis

附睾 - 睾丸炎
  • 文章类型: Journal Article
    急性附睾-睾丸炎的睾丸后果在长期损害中仍未阐明。这可能是男性不育的一个被忽视的因素。在这项研究中,在第1天,第7天和第28天,通过流式细胞术分析了脂多糖(LPS)诱导的小鼠附睾-睾丸炎中睾丸免疫细胞亚群的差异表型.巨噬细胞的数量,中性粒细胞,和骨髓来源的抑制细胞(MDSC)在接种后睾丸中稳步下降。总的F4/80-CD11c+树突状细胞(DCs)维持相对稳定的水平,而常规1型树突状细胞(cDC1)从第1天到第28天逐渐增加。在第1天和第7天存在较低数量的CD4+和CD8+T细胞,并且它们在第28天具有相似的结果,具有上限水平。睾丸显示较高水平的CD3+T细胞,但巨噬细胞的频率较低,与附睾相比,cDC2和接种后28天的嗜中性粒细胞。总之,我们的数据表明急性附睾-睾丸炎可能导致睾丸的长期损伤,其特征在于CD3+T细胞(包括CD4+和CD8+T细胞)介导的免疫应答。
    The testicular consequences of acute epididymo-orchitis remain largely unelucidated in long-term damage, which might be a neglected factor for male infertility. In this study, the differential phenotype of testicular immune cell subpopulations in lipopolysaccharide (LPS)-induced mouse epididymo-orchitis were analyzed by flow cytometry on day 1, day 7, and day 28. The number of macrophages, neutrophils, and myeloid-derived suppressor cells (MDSCs) steadily decreased in the testes with inoculation. Total F4/80-CD11c+ dendritic cells (DCs) maintained a relatively stable level, whereas conventional type 1 dendritic cells (cDC1) increased gradually from day 1 to day 28. There was a lower number of CD4+ and CD8+ T cells at day 1 and day 7, and they had similar results with a ceiling level at day 28. The testes displayed a higher level of CD3+ T cells but a lower frequency of macrophages, cDC2, and neutrophils at 28 days post-inoculation compared with the epididymis. In summary, our data indicates acute epididymo-orchitis could lead to long-term damage in the testes, which is characterized by CD3+ T cell (including CD4+ and CD8+ T cells)-mediated immune responses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    睾丸坏死是免疫球蛋白A(IgA)血管炎(IgAV)的罕见且严重的并发症。在这里,我们报告了一例10岁男孩,因皮肤紫癜和间歇性腹痛10天,双侧睾丸疼痛2天而入院。阴囊超声显示右睾丸缺血,右附睾-睾丸炎,和双侧睾丸鞘膜积液。阴囊手术探查显示右睾丸明显肿胀和变黑。保守治疗使他的病情好转,他出院了.在3个月的随访中,没有皮肤紫癜或疼痛复发,尿检正常.彩超显示右侧睾丸组织仅有部分血流信号,比左睾丸略小。这种情况突出表明,在IgAV的诊断和治疗过程中,临床医生需要持续关注生殖系统的体征和症状。用超声波连续监测可以帮助早期检测,诊断,及治疗生殖系统病变的IgA血管炎。
    Testicular necrosis is a rare and severe complication of immunoglobulin A (IgA) vasculitis (IgAV). Herein, We report a case of a 10-year-old boy who was admitted to the hospital due to skin purpura and intermittent abdominal pain for 10 days and bilateral testicular pain for 2 days. Scrotal ultrasonography indicated right testicle ischemia, right epididymo-orchitis, and bilateral hydrocele of the testis. Scrotal surgical exploration revealed significant swelling and darkening of the right testicle. Conservative treatment led to improvement in his condition, and he was discharged. During 3 months of follow-up, there was no recurrence of skin purpura or pain, and the urine tests were normal. Color ultrasound indicated only partial blood flow signal to the right testicle tissue, which was slightly smaller than the left testicle. This case highlights the need for continuous attention from clinicians to the signs and symptoms of the reproductive system during the diagnosis and treatment of IgAV. Continuous monitoring with ultrasound can aid in early detection, diagnosis, and treatment of reproductive system lesions of IgA vasculitis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    结核性附睾-睾丸炎是膀胱内卡介苗(BCG)免疫治疗膀胱癌的罕见并发症。我们报告了一名患有膀胱癌并有膀胱内BCG免疫治疗史的患者,该患者出现右阴囊疼痛1周。一个异质的,低回声,阴囊超声图上可见右侧睾丸血流量增加的固体肿块。尿液普通和结核病培养产生阴性结果。在抗生素治疗失败和无法排除肿瘤后,诊断通过根治性睾丸切除术得到证实.肿瘤及肿瘤组织脓液抗酸染色阳性,脓液培养对结核分枝杆菌复合体呈阳性。进行了右睾丸根治性切除术,利福平抗结核治疗,异烟肼,乙胺丁醇,并给予吡嗪酰胺。病人目前仍在抗结核治疗中,没有发现明显的不良反应。如果通常用于治疗普通附睾-睾丸炎的经验性抗生素治疗失败,则有膀胱内BCG免疫治疗史的患者应怀疑与BCG相关的附睾-睾丸炎。
    Tuberculous epididymo-orchitis is a rare complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer. We report a patient with bladder cancer and a history of intravesical BCG immunotherapy who presented with right scrotal pain for 1 week. A heterogeneous, hypoechoic, and solid mass surrounded by increased blood flow in the right testis was seen on scrotal echogram. Urine ordinary and tuberculosis culture yielded negative results. After failure of antibiotic treatment and the inability to rule out tumor, the diagnosis was confirmed by radical orchiectomy. Acid-fast staining of pus in the tumor and tumor tissue was positive, and a pus culture was positive for Mycobacteria tuberculosis complex. Right radical orchiectomy was performed, and anti-tuberculosis treatment with rifampicin, isoniazid, ethambutol, and pyrazinamide was given. The patient is still currently under anti-tuberculosis treatment, and no significant adverse effects have been noted. BCG-related epididymo-orchitis should be suspected in patients with a history of intravesical BCG immunotherapy if the empiric antibiotic treatment typically used to treat common epididymo-orchitis fails.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    BACKGROUND: Nowadays, most studies of tuberculous epididymo-orchitis (TBEO) are case reports or small sample cohort series. Our study is aimed to present the largest series of TBEO with our management experiences and long-term follow-up outcomes.
    METHODS: Patients diagnosed with TBEO after surgical procedures at Department of Urology, West China Hospital from 2008 to 2019 were included. All clinical features, auxiliary examination results, treatment and histopathological findings were extracted if available.
    RESULTS: Eighty-one patients (mean age 50.77 ± 16.1 years) were included. Scrotal swelling (N = 47, 58.0%) and pain (N = 29, 35.8%) were the most common presenting complaint. Pyuria and microscopic hematuria were observed in twenty-two (27.2%) and eight patients (9.9%), respectively. Urine acid fast bacilli cultures were available in 16 patients and all were negative. The mean duration between the onset of symptoms and the definite diagnosis was 6.42 ± 7.0 months. TBEO was considered in 30 (37.0%), tumors in 28 (34.6%) and nonspecific bacterial epididymo-orchitis in 23 (28.4%) patients. All patients received triple therapy of chemotherapy-surgery-pharmacotherapy and definite diagnosis was confirmed through histopathology of surgical specimens. Fifty-five patients were followed up regularly (mean follow-up 82.35 ± 36.6 months). One patient (1.2%) died from liver cirrhosis and no recurrence was observed. Postoperative complications included erectile dysfunction in 4 patients (4.9%), premature ejaculation in 5 patients (6.2%) and sterility in 7 patients (8.6%).
    CONCLUSIONS: We recommend patients with advanced TBEO to receive triple therapy of chemotherapy-surgery-pharmacotherapy. Physicians should pay more attention to patients\' sexual function and fertility during follow up after treatment completed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号